Fine Mapping of Chromosome 6q23-25 Region in Familial Lung Cancer Families Reveals RGS17 as a Likely Candidate Gene
暂无分享,去创建一个
Marshall W. Anderson | D. Seminara | J. Minna | Yan Lu | C. Amos | M. You | L. Girard | A. Gazdar | J. Long | X. Shu | Y. Xiang | W. Zheng | W. Chow | J. Cunningham | M. James | Peng-Yuan Liu | H. Vikis | Zhifu Sun | Ping Yang | M. de Andrade | G. Petersen | J. Bailey-Wilson | Yanhong Wu | P. Fain | A. Schwartz | J. Wiest | Yian Wang | Daolong Wang | D. Mandal | S. Pinney | E. Kupert | C. Gaba | H. Rothschild | T. Coons | N. Rothman | W. Wen | Min Wang | Juwon Lee | Yu-Tang Gao | D. Jia | Yan Liu | Qiong Chen | Pengyuan Liu | Yu-Tang Gao | Yu-Tang Gao | Zhifu Sun | G. Petersen | Weidong Wen | Michael R. James
[1] Yan Lu,et al. RGS17, an overexpressed gene in human lung and prostate cancer, induces tumor cell proliferation through the cyclic AMP-PKA-CREB pathway. , 2009, Cancer research.
[2] D. Lake,et al. Dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by weekly paclitaxel (P) with trastuzumab (T) and lapatinib (L) in HER2/neu-positive breast cancer is not feasible due to excessive diarrhea: updated results. , 2009 .
[3] Marshall W. Anderson,et al. Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer. , 2008, Journal of the National Cancer Institute.
[4] S. Senogles. D2 dopamine receptor-mediated antiproliferation in a small cell lung cancer cell line, NCI-H69 , 2007, Anti-cancer drugs.
[5] A. Børresen-Dale,et al. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes , 2007, Oncogene.
[6] R. A. Hunt,et al. RGSZ1 interacts with protein kinase C interacting protein PKCI-1 and modulates mu opioid receptor signaling. , 2007, Cellular signalling.
[7] M. Brock,et al. Imaging δ- and μ-Opioid Receptors by PET in Lung Carcinoma Patients , 2007 .
[8] L. Tanoue. Clinical Features of 5,628 Primary Lung Cancer Patients: Experience at Mayo Clinic From 1997 to 2003Yang P, Allen MS, Aubry MC, et al (Mayo Clinic, Rochester, Minn) Chest 128:452-462, 2005§ , 2007 .
[9] D. Schaid,et al. Exact tests of Hardy-Weinberg equilibrium and homogeneity of disequilibrium across strata. , 2006, American journal of human genetics.
[10] X. Shu,et al. Environmental tobacco smoke and mortality in Chinese women who have never smoked: prospective cohort study , 2006, BMJ : British Medical Journal.
[11] J. Gu,et al. Breast cancer incidence in U.S. radiologic technologists , 2006, Cancer.
[12] P. Albert,et al. RGS17/RGSZ2 and the RZ/A family of regulators of G-protein signaling. , 2006, Seminars in cell & developmental biology.
[13] Terence P. Speed,et al. Genome analysis A genotype calling algorithm for affymetrix SNP arrays , 2005 .
[14] K. Yarasheski,et al. Alterations in thigh subcutaneous adipose tissue gene expression in protease inhibitor-based highly active antiretroviral therapy. , 2005, Metabolism: clinical and experimental.
[15] Mark Daly,et al. Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..
[16] L. Liotta,et al. A Functional Polymorphism in RGS6 Modulates the Risk of Bladder Cancer , 2004, Cancer Research.
[17] Marshall W. Anderson,et al. A major lung cancer susceptibility locus maps to chromosome 6q23-25. , 2004, American journal of human genetics.
[18] P. Albert,et al. RGS17/RGSZ2, a Novel Regulator of Gi/o, Gz, and Gq Signaling* , 2004, Journal of Biological Chemistry.
[19] L. Liotta,et al. A Functional Polymorphism in RGS 6 Modulates the Risk of Bladder Cancer , 2004 .
[20] S. Gabriel,et al. The Structure of Haplotype Blocks in the Human Genome , 2002, Science.
[21] Claude Deschamps,et al. Polymorphisms in the promoter region of the neutrophil elastase gene are associated with lung cancer development. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[22] D E Weeks,et al. Multipoint Estimation of Identity-by-Descent Probabilities at Arbitrary Positions among Marker Loci on General Pedigrees , 2001, Human Heredity.
[23] G. Swanson,et al. Lung cancer risk in families of nonsmoking probands: Heterogeneity by age at diagnosis , 1999, Genetic epidemiology.
[24] K Lange,et al. Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics. , 1996, American journal of human genetics.
[25] J. Minna,et al. Opioids induce while nicotine suppresses apoptosis in human lung cancer cells. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[26] T. Sellers,et al. Segregation analysis of smoking-associated malignancies: evidence for Mendelian inheritance. , 1994, American journal of medical genetics.
[27] M. Fukayama,et al. Inhibition of growth of human small cell lung cancer by bromocriptine. , 1994, Cancer research.
[28] J. Brugge. Origins of human cancer : a comprehensive review , 1991 .
[29] T. Sellers,et al. Association of incident lung cancer with family history of female reproductive cancers: The Iowa women's health study , 1991, Genetic epidemiology.
[30] T. Sellers,et al. Evidence for mendelian inheritance in the pathogenesis of lung cancer. , 1990, Journal of the National Cancer Institute.
[31] J. Minna,et al. Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[32] S. Steiner. The Mexican Americans , 1979 .
[33] W. Blattner,et al. Varied manifestations of a familial lymphoproliferative disorder. , 1975, The American journal of medicine.
[34] A. Lilienfeld,et al. Familial aggregation of lung cancer in humans. , 1963, Journal of the National Cancer Institute.
[35] L. Friberg,et al. Smoking Habits of Monozygotic and Dizygotic Twins , 1959, British medical journal.
[36] W. Haenszel,et al. Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.
[37] C. Heath. Differences between smokers and nonsmokers. , 1958, A.M.A. archives of internal medicine.
[38] A. Motulsky. Drug reactions enzymes, and biochemical genetics. , 1957, Journal of the American Medical Association.